GlassScriptPhysician profile
Chad Michael Gridley
NPI 1396180717
$3,393.84
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,349 · 2020: $35.61 · 2021: $416 · 2022: $267 · 2023: $305 · 2024: $20.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,732.56 | 2019-2024 | Lithovue, Lumenis Pulse 120h |
| Karl Storz Endoscopy-America | $1,361.55 | 2019 | |
| Teleflex LLC | $100.00 | 2021 | |
| Avanir Pharmaceuticals, INC. | $48.48 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $32.49 | 2021 | |
| Amneal Pharmaceuticals LLC | $24.75 | 2020-2021 | |
| Acorda Therapeutics, INC | $23.74 | 2020-2021 | |
| Ucb, INC. | $18.78 | 2021 | |
| Emd Serono, INC. | $14.67 | 2021 | |
| Lilly USA, LLC | $13.05 | 2021 | |
| Neurelis, INC. | $12.34 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Gridley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.